Tabs
Elizabeth Chrischilles PhD, MS; Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA
Azadeh Shoaibi MS, MHS; Office of Medical Policy, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Marsha Reichman PhD; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Ryan Carnahan PharmD, MS, BCPP; Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA
Joshua Gagne PharmD, ScD; Shirley Wang PhD; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Jennifer Nelson PhD; Biostatistics Unit, Group Health Research Institute and Department of Biostatistics, University of Washington, Seattle, WA
Bruce Fireman MA; Kaiser Permanente Northern California, Oakland, CA
Rongmei Zhang PhD; Mark Levenson PhD; Aloka Chakravarty PhD; Division of Biometric VII, Office of Biostatistics, Office of Translation Sciences, FDA, Silver Springs, MD
David Graham MD, MPH; Ram Tiwari PhD; Mary Ross Southworth PharmD; Margie Goulding PhD; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Patrick Archdeacon MD, MS; Office of Medical Policy, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Rima Izem PhD, Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Jeffrey Brown PhD; Candace Fuller PhD; Catherine Rogers MPH; Darren Toh ScD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA